HXL

10.0%

1.1¢ hexima limited.

HXL transitioning to commercial success, page-2

First 2 Last

Share
Profile

Follow
valueadd

5,623 Posts.

1769

02/12/21

10:42

Post #: 58016672
Share

Originally posted by valueadd ↑

Looks like HXL aren't wasting time getting things into gear
in readiness for the next step of their evolution

Some key people appointments

For those who think the stock is a sleeper I suggest you
do a bit of R & D on Michael Aldridge the MD

He seems to have a pretty good track record of creating value
and the few times I've heard him speak live - he is focused and to the point

Michael Aldridge

Executive Director, Chief Executive Officer
Mr Aldridge most recently served as Senior Vice President, Corporate & Strategic Development of Codexis from October 2016 until August 2018. Prior to that, from January 2012 to September 2014, Mr. Aldridge served as Senior Vice President, Corporate Strategic Development for Questcor Pharmaceuticals, Inc., a publicly-traded biopharmaceutical company acquired by Mallinckrodt Pharmaceuticals in 2014. From May 2010 to September 2012, Mr. Aldridge served as Chief Executive Officer and a member of the board of directors for Xenome Limited, a privately-held biopharmaceutical company headquartered in Australia.
Between 2003 and 2009, Mr. Aldridge served as Chief Executive Officer and a member of the board of directors and a strategic consultant of Peplin, Inc., a publicly-traded drug development company acquired by LEO Pharma A/S in 2009. Prior to that, Mr. Aldridge held investment banking positions at various financial firms, including Wilson HTM Investment Group, Bear, Stearns & Co., Volpe, Brown, Whelan & Company and S.G. Warburg Group. Mr. Aldridge received a B.S. in Chemistry from the University of Canterbury in Christchurch, New Zealand and an M.S. in Applied Finance from Macquarie University in Sydney, Australia.

Expand

Note - clearly the two people appointments made are at the academic / scientific end of the spectrum . Important placements in terms of compounding credibility and obtaining the clinical milestones for approvals etc .

HXL's intended & planned sales rout of product will be through GP's & Specialists etc via prescription

The product wont be cheap - but speaking from personal experience ... I've tried just about every over the counter topically applied product on the market over time ...without much success

Give me something that works .!!!!

https://hexima.com.au/technology/

Cheers

HXL Price at posting: 33.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

RCE

Recce's R327 found effective against E.coli during clinical trial

Microcap Wrap: 5 explorers with news out today

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

There are more pages in this discussion • 6 more messages in this thread...

First 2 Last

Add HXL (ASX) to my watchlist

(20min delay)
Last 1.1¢		Change 0.001(10.0%)		Mkt cap ! $1.837M

Open	High	Low	Value	Volume
1.0¢	1.1¢	1.0¢	$625	57.19K

Buyers (Bids)

No.	Vol.	Price($)
1	26725	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.4¢	485433	1

View Market Depth

No.	Vol.	Price($)
1	26725	0.011
1	44724	0.010
2	333330	0.009
4	775115	0.008
4	1182394	0.007

Price($)	Vol.	No.
0.014	485433	1
0.018	350000	1
0.029	131000	1
0.089	250000	1
0.090	41670	1

Last trade - 15.47pm 28/06/2024 (20 minute delay)

HXL (ASX) Chart

HXL transitioning to commercial success, page-2

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Microcap Wrap: 5 explorers with news out today

Ava Risk Group expands US presence with A$0.7M Substation Deal

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

HXL transitioning to commercial success, page-2

Top Stories

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Microcap Wrap: 5 explorers with news out today

Ava Risk Group expands US presence with A$0.7M Substation Deal

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News